Latest News about Biotechnology
Recent news which mentions Biotechnology
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
October 30, 2024
From CNBC.com News
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
October 29, 2024
From CNBC.com News
CDC says 75 people affected in E. coli outbreak linked to McDonald's Quarter Pounders
October 25, 2024
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
October 24, 2024
From CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
October 23, 2024
From CNBC.com News
Drug costs, abortion, Obamacare: How Trump and Harris could change U.S. health care
October 19, 2024
Tickers
LAWS
From CNBC.com News
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
October 17, 2024
From CNBC.com News
Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plunge
October 16, 2024
From CNBC.com News
From CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
October 11, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
September 26, 2024
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
September 25, 2024
From CNBC.com News
From CNBC.com News
FTC sues drug middlemen for allegedly inflating insulin prices
September 20, 2024
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free